BRAIN DIGITAL TWINS

# Record card
333
Thematic areas
Health & Biotech
Health & Biotech / Bio-medicals
Health & Biotech / Bio-informatics
Health & Biotech / Medical Device
ICT & Electronics
ICT & Electronics / IT and Telematics applications
ICT & Electronics / Artificial Intelligence
Description

Brain Digital Twins represent the most advanced multiscale computational modelling technology for personalized and precision medicine. Brain Digital Twins allow you to study the normal and pathological brain functions of individual neurological and psychiatric subjects. Brain Digital Twins are based on detailed clinical, neuropsychological and instrumental analyses (nuclear magnetic resonance imaging and electroencephalography) and allow to extract information not otherwise detectable through the diagnostic evaluation about synaptic efficiency, excitation/inhibition ratio, and connectivity of brain circuits. Brain Digital Twins can be used to improve diagnosis and predict disease evolution and to define the most appropriate pharmacological and interventional approach, supporting clinical decisions and improving patient profiling.

Type of innovation
Product innovation
Service/know how innovation
Description of innovative features / Competitive advantages

For the first time in Italy we have developed the Brain Digital Twin, i.e. a computational model that replicates in detail the brain functions of individual subjects and allows us to identify their alterations during neurological and psychiatric diseases. This approach exploits some of the most advanced technologies in computational neuroscience: data obtained from nuclear magnetic resonance imaging (MRI) are used to reconstruct the brain's system of connections and functional models of brain areas reproduce their structural and functional characteristics. Digital Brain Twin simulations allow you to extract key parameters that cannot be obtained with other methods, improving patient profiling and supporting clinical and therapeutic decisions, diagnosis and prognosis.

Reference market
Incremental innovation
Impacts on existing markets
Development stage
Feasibility
TRL
3
4
Advantages
New product/process/service/technology
Cost reduction
Patentable technology
No
Patented technology
No
Publication of technology
Published
Technology validation/demonstration
Internal validation
Market positioning
Italian
European
International
Partner required
Enteprise
Public research center/university
Private research center
Seed capital
Cooperation in national /european / international project

Information
For more information and/or to be put in contact with the Research Team, please contact the Project Manager:

Barbara Angelini - Project Manager
CNR - Unità Valorizzazione della Ricerca
Phone number 06.49932415
E-mail barbara.angelini@cnr.it